64312 Federal Register / Vol. 69, No. 213 / Thursday, November 4, 2004 / Notices 

their institutions on issues related to 

institutional policies, and local IRB 

rules, as well as local, State and Federal 

laws and regulations, including the 

Privacy Rule. 

Further detail on the requirements for 

addressing data sharing in applications 

for NCIPC funding may be obtained by 

contacting NCIPC program staff or by 

visiting the NCIPC Internet at: http://

www.cdc.gov/ncipc/osp/

sharing_policy.htm. 

VI.3. Reporting 

You must provide CDC with an 

original, plus two hard copies of the 

following reports: 

1. Interim progress report, (use form 

PHS 2590, OMB Number 0925–0001, 

rev. 5/2001 as posted on the CDC Web 

site) no less than 90 days before the end 

of the budget period. The progress 

report will serve as your non-competing 

continuation application, and must 

contain the following elements: 

a. Current Budget Period Activities 

Objectives. 

b. Current Budget Period Financial 

Progress. 

c. New Budget Period Program 

Proposed Activity Objectives. 

d. Budget. 

e. Measures of Effectiveness. 

f. Additional Requested Information. 

2. Financial status report, no more 

than 90 days after the end of the budget 

period. 

3. Final financial and performance 

reports, no more than 90 days after the 

end of the project period. 

4. At the completion of the project, 

the grant recipient will submit a brief 

summary 2,500 to 4,000 words written 

in non-scientific [laymen’s] terms. The 

narrative should highlight the findings 

and their implications for injury 

prevention programs, policies, 

environmental changes, etc. The grant 

recipient will also include a description 

of the dissemination plan for research 

findings. This plan will include 

publications in peer-reviewed journals 

and ways in which research findings 

will be made available to stakeholders 

outside of academia (e.g., state injury 

prevention program staff, community 

groups, public health injury prevention 

practitioners, and others). CDC will 

place the summary report and each 

grant recipient’s final report with the 

National Technical Information Service 

(NTIS) to further the agency’s efforts to 

make the information more available 

and accessible to the public. 

These reports must be mailed to the 

Grants Management Specialist listed in 

the ‘‘Agency Contacts’’ section of this 

announcement. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement. 

For general questions, contact: 

Technical Information Management 

Section, CDC Procurement and Grants 

Office, 2920 Brandywine Road, Atlanta, 

GA 30341. Telephone: (770) 488–2700.

For scientific/research issues, contact: 

Paul Smutz, Ph.D, Project Officer, 

National Center for Injury Prevention 

and Control, Centers for Disease Control 

and Prevention (CDC), 4770 Buford 

Highway, NE., Mailstop K–02, Atlanta, 

GA 30341. Telephone: (770) 488–1508; 

e-mail: wsmutz@cdc.gov. 

For questions about peer review, 

contact: Gwendolyn Cattledge, Ph.D, 

Scientific Review Administrator, 

National Center for Injury Prevention 

and Control, Centers for Disease Control 

and Prevention (CDC), 4770 Buford 

Highway, NE., Mailstop K–02, Atlanta, 

GA 30341. Telephone: (770) 488–1430; 

e-mail: gxc8@cdc.gov. 

For financial, grants management, or 

budget assistance, contact: Pamela 

Render, Grants Management Specialist, 

CDC Procurement and Grants Office, 

2920 Brandywine Road, Atlanta, GA 

30341. Telephone: (770) 488–2712; email: PLR3@cdc.gov. 

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC Web site, Internet 

address: http://www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–24618 Filed 11–3–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: National Medical Support 

Notice. 

OMB No.: 0970–0222. 

Description: The information 

collected by state IV–D child support 

enforcement agencies is used to 

complete the National Medical Support 

Notice (NMSN) that is sent to employers 

of employee/obligors and used as a 

means of enforcing the health care 

coverage provision in a child support 

order. Primarily, the information the 

state child support enforcement 

agencies use to complete the NMSN is 

information regarding appropriate 

persons that is necessary for the 

enrollment of the child in employmentrelated health care coverage, such as the 

employee/obligor’s name, address, and 

Social Security number; the employer’s 

name and address: the name and 

address of the alternate recipient (child); 

and the custodial parent’s name and 

address. The employer forwards the 

second part of the NMSN to the group 

health plan administrator, which 

contains the same individual identifying 

information. The plan administrator 

requires this information to determine 

whether to enroll the alternate recipient 

in the group health plan. If necessary, 

the employer also initiates withholding 

from the employee’s wages for the 

purpose of paying premiums to the 

group health plan for enrollment of the 

child. 

Respondents: State and local title IV–

D child support enforcement agencies 

initiate the process of enforcing medical 

health care coverage for the child by 

completing and sending the notice to 

known employers of the noncustodial 

parents (employee/obligor). Employers 

and plan administrators are on the 

receiving end of the notice. 

Annual Burden Estimates:

Instrument Number of

respondents 

Number of

responses per

respondent 

Average burden

hours per

response 

Total burden

hours 

45 CFR 303.32 ................................................................................ 54 13,454 .17 123,507 

Estimated Total Annual Burden 

Hours: 123,507. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Federal Register / Vol. 69, No. 213 / Thursday, November 4, 2004 / Notices 64313

Washington, DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

grjohnson@acf.hhs.gov.

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Attn: Desk Officer for 

ACF, E-mail address: 

Katherine_T._Astrich@omb.eop.gov.

Dated: October 28, 2004. 

Robert Sargis, 

Reports Clearance Officer.

[FR Doc. 04–24600 Filed 11–3–04; 8:45 am] 

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Provision of Services in 

Interstate Child Support Enforcement: 

Standard Forms. 

OMB No.: 0970–0085. 

Description: Pub. L. 104–193, the 

Personal Responsibility and Work 

Opportunity Reconciliation Act of 1996, 

amended 42 U.S.C. 666 to require State 

Child Support Enforcement (CSE) 

agencies to enact the Uniform Interstate 

Family Support Act (UIFSA) into State 

law by January 1, 1998. Section 311(b) 

of UIFSA requires the States to use 

standard interstate forms, as mandated 

by Federal law. 45 CFR 303.7 also 

requires CSE programs to transmit child 

support case information on standard 

interstate forms when referring cases to 

other States for processing. During the 

OMB clearance process, we are taking 

the opportunity to make revisions that 

have been requested by the States. 

Respondents: State agencies 

administering the Child Support 

Enforcement program under title IV–D 

of the Social Security Act. 

Annual Burden Estimates:

Instrument Number of

respondents 

Number of

responses per

respondent 

Average burden 

hours per

response 

Total burden

hours 

Transmittal 1 .................................................................................... 54 19,278 .25 260,253 

Transmittal 2 .................................................................................... 54 14,458 .08 62,459 

Transmittal 3 .................................................................................... 54 964 .08 4,164 

Uniform Petition ............................................................................... 54 9,639 .08 41,640 

General Testimony .......................................................................... 54 11,567 .33 206,124 

Affidavit Paternity ............................................................................. 54 4,819 .17 44,238 

Locate Data Sheet ........................................................................... 54 375 .08 1,620 

Notice of Controlling Order .............................................................. 54 964 .08 4,164 

Registration Statement .................................................................... 54 8,675 .08 37,476 

Estimated Total Annual Burden 

Hours: 662,138. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

grjohnson@acf.hhs.gov.

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Attn: Desk Officer for 

ACF, E-mail address:

Katherine_T._/Astrich@omb.eop.gov.

Dated: October 27, 2004. 

Robert Sargis, 

Reports Clearance Officer.

[FR Doc. 04–24601 Filed 11–3–04; 8:45 am] 

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

[Docket No. 2000N–1409]

Medical Devices; Reclassification of 

the Iontophoresis Device

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice of intent.

SUMMARY: The Food and Drug 

Administration (FDA) announces an 

opportunity to submit information and 

comments concerning FDA’s intent to 

initiate a proceeding to reclassify those 

iontophoresis devices currently in class 

III (premarket approval) into class II 

(special controls). An iontophoresis 

device is a device that is intended to use 

a direct current to introduce ions of 

soluble salts or other drugs into the 

body and induce sweating for diagnostic 

or other uses. Elsewhere in this issue of 

the Federal Register, FDA is 

withdrawing the proposed rule the 

agency issued in the Federal Register of 

August 22, 2000 (65 FR 50949) (the 

August 2000 proposed rule).

DATES: Submit written or electronic 

comments by February 2, 2005.

ADDRESSES: Submit written comments 

to the Division of Dockets Management 

(HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. Submit 

electronic comments to http://

www.fda.gov/dockets/ecomments.

FOR FURTHER INFORMATION CONTACT:

Joseph M. Sheehan, Center for Devices 

and Radiological Health (HFZ–215), 

Food and Drug Administration, 1350 

Piccard Dr., Rockville, MD 20850, 301–

827–2974.

SUPPLEMENTARY INFORMATION:

I. Background

In the Federal Register of November 

23, 1983 (48 FR 53032), FDA issued a 

final rule classifying the iontophoresis 

device into class II (performance 

standards before the Safe Medical 

Devices Act of 1990 and now special 

controls) and class III (premarket 

approval), depending on its intended 

use. An iontophoresis device is a device